Latest News about SNY
Recent news which mentions SNY
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
October 04, 2024
Tickers
CSLLY
GSK
NEWS
SNY
Tags
CSLLY
GSK
SNY
From
Benzinga
Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati
October 04, 2024
Tickers
NEWS
SNY
Tags
SNY
News
Briefs
From
Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
October 04, 2024
Tickers
AZN
MRK
NEWS
NVO
Tags
Stories That Matter
SNY
News
From
Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
Tickers
AZN
LLY
NEWS
NVO
Tags
Government
General
Regulations
From
Benzinga
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
September 27, 2024
Tickers
NEWS
REGN
SNY
Tags
Stories That Matter
Top Stories
Movers
From
Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
September 25, 2024
Tickers
AMGN
LLY
NEWS
SNY
Tags
Health Care
Equities
Biotech
From
Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
September 25, 2024
Tickers
AMGN
CGEM
NEWS
REGN
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Tickers
GS
GSK
HLN
JNJ
Tags
Benzinga
MS
Media
From
Benzinga
Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences
September 23, 2024
Tickers
NEWS
SNY
VTYX
Tags
Movers
News
Briefs
From
Benzinga
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
September 23, 2024
Tickers
NEWS
SNY
Tags
Biotech
Large Cap
Briefs
From
Benzinga
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
September 20, 2024
Tickers
CI
CVS
LLY
NEWS
Tags
General
CI
Legal
From
Benzinga
Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows
September 20, 2024
Tickers
NEWS
SNY
Tags
Benzinga
Top Stories
Stories That Matter
From
Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
September 18, 2024
Tickers
NEWS
NVS
SNY
Tags
Health Care
Biotech
Large Cap
From
Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
SNY
MRNA
BNTX
From
Motley Fool
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
September 11, 2024
Tickers
NEWS
REGN
SNY
Tags
REGN
General
Health Care
From
Benzinga
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
Tickers
BMRN
BMY
GSK
LLY
Tags
BMY
Health Care
AI Generated
From
Benzinga
Why Sanofi Stock Was Robustly Healthy Today
September 03, 2024
Tickers
SNY
Tags
Recent Press Releases
SNY
Market News
From
Motley Fool
Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials
September 03, 2024
Tickers
NEWS
SNY
Tags
Health Care
Large Cap
Biotech
From
Benzinga
European Stocks Little Moved On Labor Day, German DAX Mark Record Close, Natural Gas Futures Rise: What's Driving Markets Monday?
September 02, 2024
Tickers
BBSRF
BMWYY
BX
EADSY
Tags
BBSRF
ORAN
SNY
From
Benzinga
Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
August 26, 2024
Tickers
LLY
NEWS
NVO
SNY
Tags
Stories That Matter
General
News
From
Benzinga
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
August 24, 2024
Tickers
NVAX
SNY
Tags
SNY
Market News
NVAX
From
Motley Fool
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
August 20, 2024
Tickers
NEWS
SNY
SPRY
Tags
Stories That Matter
Top Stories
Expert Ideas
From
Benzinga
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
August 16, 2024
Tickers
GSK
NEWS
PFE
SNY
Tags
Benzinga
PFE
Market News
From
Benzinga
3 Biotech Stocks to Buy on the Dip: August 2024
August 15, 2024
Tickers
LLY
SNY
VRTX
Tags
Market News
NYSE:LLY,NASDAQ:SNY,NASDAQ:VRTX
Uncategorized
From
InvestorPlace
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
August 09, 2024
Tickers
NEWS
SNY
SPRY
Tags
Health Care
SPRY
Biotech
From
Benzinga
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
August 08, 2024
Tickers
NEWS
NVAX
SNY
Tags
Movers
Earnings
why it's moving
From
Benzinga
Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant
August 08, 2024
Tickers
NEWS
SNY
Tags
Benzinga
Market News
Stories That Matter
From
Benzinga
Where Will Novavax Be in 5 Years?
August 03, 2024
Tickers
MRNA
NVAX
SNY
Tags
Recent Press Releases
NVAX
Market News
From
Motley Fool
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
August 01, 2024
Tickers
NEWS
REGN
SNY
Tags
Stories That Matter
Guidance
Top Stories
From
Benzinga
JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
July 31, 2024
Tickers
JPM
MCD
NVAX
SNY
Tags
ULCC
Market News
NVAX
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.